TINA HACKNEY: Open Payments
NPI 1306997218 · BURLINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,449 in 73 payments from 18 companies in 2025. Trend: 2023 $391 · 2024 $2,114 · 2025 $1,449
Food & beverage: $1,350Education: $99
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 9 | $253 |
| Merck Sharp & Dohme LLC | 13 | $222 |
| Alnylam Pharmaceuticals Inc. | 10 | $146 |
| AstraZeneca Pharmaceuticals LP | 9 | $143 |
| ABIOMED | 1 | $140 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $97 |
| Novartis Pharmaceuticals Corporation | 4 | $77 |
| SCPHARMACEUTICALS INC. | 4 | $69 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $69 |
| Novo Nordisk Inc | 3 | $47 |
Products named: OPSUMIT, ONPATTRO, VERQUVO, FARXIGA, JARDIANCE, LEQVIO, FUROSCIX, Kerendia.
Industry payments across NC — which companies pay providers there.
